TABLE 2

Comparisons of allele frequencies in the Norwegian sample of 1,644 type 2 diabetic and 1,879 control subjects

Marker	Position (bp)†	Minor/major allele	Minor allele frequency			Allelic OR*
Marker	Position (bp)†	Minor/major allele				Case subjects	Control subjects	OR (95% CI)	P
rs1884613	−3925	G/C	0.198	0.181	1.17 (1.03–1.35)	0.02
rs2144908	1377	A/G	0.197	0.178	1.21 (1.05–1.38)	0.007
rs6103716	15290	C/A	0.339	0.338	1.03 (0.92–1.16)	0.57
rs6065725	20675	A/G	0.314	0.316	0.99 (0.88–1.11)	0.89
rs6017335	26485	A/G	0.486	0.467	1.06 (0.96–1.18)	0.26
rs6031580	30941	A/G	0.272	0.280	0.96 (0.85–1.08)	0.46
rs4812831	33920	A/G	0.113	0.097	1.21 (1.02–1.44)	0.03
rs3092370	35763	A/G	0.469	0.482	0.93 (0.83–1.03)	0.16
rs717248	41265	G/A	0.030	0.032	0.96 (0.70–1.32)	0.81
rs717247	41444	G/A	0.301	0.313	0.93 (0.83–1.05)	0.24
rs1028583	66421	T/G	0.354	0.358	0.98 (0.88–1.10)	0.76
rs3818247	73140	T/G	0.330	0.347	0.92 (0.82–1.03)	0.15

*
* Calculations based on logistic regression with age, BMI, and sex as cofactors.
†
† Position relative to start of the HNF4A P2 promotor (according to Goldenpath: hg17; dbSP: build 123).